The Mesothelioma Guide Blog

Opdivo and Yervoy are helping people with pleural mesothelioma live longer. Could the same happen for people with peritoneal mesothelioma? The U.S. Food and Drug Administration...

Using checkpoint inhibitors is the latest hot‑button topic among oncologists and cancer specialists. Mesothelioma is no different. Most use immune checkpoint inhibitors, a form...

With bankruptcy in mind, Johnson & Johnson took another big shot in its fight against mesothelioma claims. According to a report from Bloomberg Law, a California appellate...

Is the internet trustworthy? That’s a loaded question, one without a clear‑cut answer. Zoom in a little closer: Is the internet trustworthy for researching cancer? It’s a...

The top mesothelioma cancer centers in the world offer experienced staff, plenty of treatment options and additional support resources. There’s a subset within the segment of...

A popular oral chemotherapy for treating genetic mutations is the focus of a new clinical trial for mesothelioma. The drug, olaparib, is a maintenance therapy for advanced ovarian...

Since the start of the COVID‑19 coronavirus pandemic, use of the term “immunocompromised” has surged — and for good reason. Immunocompromised people are at the highest...

The first preference for treating mesothelioma is surgery. If you can remove the cancerous tumors in bulk, quickly, then the chances of a long and healthy life increase...

Johnson & Johnson, the manufacturer at the center of asbestos lawsuits due to contaminated talc products, is being sued by a black women’s group, according to the New York...

The U.S. Food and Drug Administration (FDA) granted ONCOFID‑P “orphan drug status” for treating malignant mesothelioma. ONCOFID‑P is a combination of paclitaxel and...